The Hemodialysis and Peritoneal Dialysis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables, Service).
Hemodialysis and peritoneal dialysis are renal replacement therapies used to treat patients with end-stage renal disease (ESRD) by removing waste products and excess fluid from the blood when the kidneys are no longer able to perform these functions adequately. In 2024, hemodialysis and peritoneal dialysis remain critical components of renal care, providing life-sustaining treatment to patients with kidney failure. Hemodialysis involves the use of a dialysis machine to filter blood through a dialyzer, which acts as an artificial kidney, removing waste products and excess fluid before returning the cleansed blood to the body. This process typically takes place in a dialysis center or hospital setting and requires regular sessions lasting several hours, usually performed three times per week. Peritoneal dialysis, on the other hand, involves the use of the patient's peritoneal membrane as a natural filter. A sterile dialysis solution is introduced into the abdominal cavity through a catheter, where it absorbs waste products and excess fluid from the bloodstream. The solution is then drained out, along with the accumulated waste, several times throughout the day, allowing for continuous removal of toxins and maintenance of fluid balance. Both hemodialysis and peritoneal dialysis offer patients with ESRD the opportunity to manage their condition and maintain a good quality of life despite kidney failure. The choice between hemodialysis and peritoneal dialysis depends on factors such as the patient's medical condition, lifestyle preferences, and accessibility to treatment facilities. While hemodialysis is more commonly used worldwide, peritoneal dialysis offers greater flexibility and independence, allowing patients to perform dialysis at home and maintain a more normal daily routine. With ongoing advancements in dialysis technology, vascular access, and patient education, hemodialysis and peritoneal dialysis continue to evolve to meet the needs of patients with kidney failure, improving outcomes and enhancing the quality of life for individuals living with ESRD.
A significant trend in the hemodialysis and peritoneal dialysis market is the increasing shift towards home dialysis solutions. As healthcare systems worldwide face challenges such as overcrowded dialysis centers, limited resources, and the need to minimize patient exposure to infectious diseases, there is a growing interest in home-based dialysis therapies. Home dialysis offers patients greater flexibility, convenience, and autonomy over their treatment schedules, allowing them to perform dialysis at their convenience in the comfort of their homes. Technological advancements in home dialysis machines, remote monitoring tools, and telehealth services enable healthcare providers to remotely monitor patients' treatment adherence, vital signs, and lab results, ensuring safe and effective home-based dialysis care. This trend is driven by factors such as the desire to improve patient quality of life, reduce healthcare costs, and enhance patient outcomes by empowering patients to take an active role in managing their kidney disease. As healthcare systems increasingly embrace home dialysis solutions as a viable alternative to in-center dialysis, the demand for home dialysis equipment, supplies, and support services is expected to grow, driving market expansion and innovation in home dialysis technologies.
A key driver fueling the hemodialysis and peritoneal dialysis market is the growing prevalence of end-stage renal disease (ESRD) worldwide. ESRD, also known as kidney failure, represents the most advanced stage of chronic kidney disease (CKD) and requires renal replacement therapy (RRT) to sustain life. Hemodialysis and peritoneal dialysis are two primary modalities of RRT used to manage ESRD and maintain patients' overall health and well-being. The rising incidence of risk factors such as diabetes, hypertension, and obesity, coupled with an aging population, contributes to the increasing prevalence of ESRD globally. As the prevalence of ESRD continues to rise, the demand for dialysis treatment options, including hemodialysis and peritoneal dialysis, is expected to increase, driving market growth and investment in dialysis equipment, consumables, and services to meet the growing healthcare needs of patients with kidney failure.
A potential opportunity in the hemodialysis and peritoneal dialysis market lies in the development of wearable dialysis devices. Traditional dialysis machines are bulky, stationary, and require patients to remain tethered to the machine for several hours during each treatment session. Wearable dialysis devices offer a more compact, portable, and discreet alternative, allowing patients to perform dialysis treatments while going about their daily activities. Wearable dialysis devices utilize miniaturized components, advanced filtration membranes, and smart monitoring technologies to deliver continuous or intermittent dialysis therapy on the go. By leveraging wearable dialysis devices, patients gain greater freedom and flexibility in managing their kidney disease, reducing treatment burden, and improving overall quality of life. Additionally, wearable dialysis devices have the potential to reduce healthcare costs associated with in-center dialysis, hospitalizations, and complications related to vascular access. By investing in the development and commercialization of wearable dialysis devices, dialysis equipment manufacturers can address the unmet needs of patients with ESRD, differentiate their product offerings, and tap into new market segments, driving innovation and market growth in the hemodialysis and peritoneal dialysis sector. Expanding into wearable dialysis devices presents a strategic opportunity for stakeholders to revolutionize dialysis care delivery, improve patient outcomes, and enhance the overall dialysis experience for patients with kidney failure.
Among the segments in the Hemodialysis and Peritoneal Dialysis Market, Automated Peritoneal Dialysis (APD) stands out as the fastest-growing type. APD's accelerated growth is primarily fueled by its convenience and effectiveness in delivering dialysis treatment to patients with end-stage renal disease (ESRD). APD automates the exchange process, allowing patients to undergo dialysis at home during sleep, thereby providing continuous therapy without the need for frequent clinic visits. This home-based approach not only enhances patient comfort and quality of life but also reduces the burden on healthcare facilities and caregivers. Furthermore, advancements in APD technology, such as the development of user-friendly devices and improved remote monitoring capabilities, further contribute to its increasing adoption. As a result, APD emerges as a pivotal driver in the expansion of the dialysis market, catering to the growing demand for efficient and patient-centric renal replacement therapies.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAsahi Kasei Corp, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Cantel Medical corp, DaVita Inc, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd, Nipro Corp
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Asahi Kasei Corp
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson and Company
Cantel Medical corp
DaVita Inc
Fresenius Medical Care AG & Co. KGaA
Medtronic plc
Nikkiso Co. Ltd
Nipro Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Hemodialysis and Peritoneal Dialysis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Hemodialysis and Peritoneal Dialysis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Hemodialysis and Peritoneal Dialysis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Hemodialysis and Peritoneal Dialysis Market Size Outlook, $ Million, 2021 to 2030
3.2 Hemodialysis and Peritoneal Dialysis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Hemodialysis and Peritoneal Dialysis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Hemodialysis and Peritoneal Dialysis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Hemodialysis and Peritoneal Dialysis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Hemodialysis and Peritoneal Dialysis Industry
4.2 Key Market Trends in Hemodialysis and Peritoneal Dialysis Industry
4.3 Potential Opportunities in Hemodialysis and Peritoneal Dialysis Industry
4.4 Key Challenges in Hemodialysis and Peritoneal Dialysis Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Hemodialysis and Peritoneal Dialysis Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Hemodialysis and Peritoneal Dialysis Market Outlook by Segments
7.1 Hemodialysis and Peritoneal Dialysis Market Outlook by Segments, $ Million, 2021- 2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
8 North America Hemodialysis and Peritoneal Dialysis Market Analysis and Outlook To 2030
8.1 Introduction to North America Hemodialysis and Peritoneal Dialysis Markets in 2024
8.2 North America Hemodialysis and Peritoneal Dialysis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Hemodialysis and Peritoneal Dialysis Market size Outlook by Segments, 2021-2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
9 Europe Hemodialysis and Peritoneal Dialysis Market Analysis and Outlook To 2030
9.1 Introduction to Europe Hemodialysis and Peritoneal Dialysis Markets in 2024
9.2 Europe Hemodialysis and Peritoneal Dialysis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Hemodialysis and Peritoneal Dialysis Market Size Outlook by Segments, 2021-2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
10 Asia Pacific Hemodialysis and Peritoneal Dialysis Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Hemodialysis and Peritoneal Dialysis Markets in 2024
10.2 Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Hemodialysis and Peritoneal Dialysis Market size Outlook by Segments, 2021-2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
11 South America Hemodialysis and Peritoneal Dialysis Market Analysis and Outlook To 2030
11.1 Introduction to South America Hemodialysis and Peritoneal Dialysis Markets in 2024
11.2 South America Hemodialysis and Peritoneal Dialysis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Hemodialysis and Peritoneal Dialysis Market size Outlook by Segments, 2021-2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
12 Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Hemodialysis and Peritoneal Dialysis Markets in 2024
12.2 Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Hemodialysis and Peritoneal Dialysis Market size Outlook by Segments, 2021-2030
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Asahi Kasei Corp
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson and Company
Cantel Medical corp
DaVita Inc
Fresenius Medical Care AG & Co. KGaA
Medtronic plc
Nikkiso Co. Ltd
Nipro Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Hemodialysis
-Conventional
-Short Daily Hemodialysis
-Nocturnal Hemodialysis
Peritoneal Dialysis
-Continuous Ambulatory Peritoneal Dialysis (CAPD)
-Automated Peritoneal Dialysis (APD)
By Product
Device
-Machine
-Dialyzers
-Water Treatment System
-Others
Consumables
-Bloodlines
-Concentrates
-Catheters
-Others
Service
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Hemodialysis and Peritoneal Dialysis Market is one of the lucrative growth markets, poised to register a 8.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Asahi Kasei Corp, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Cantel Medical corp, DaVita Inc, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd, Nipro Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume